XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 92,997 $ 79,790
Marketable investments (Note 4) 50,090 54,333
Accounts receivable, net 49,486 70,023
Deferred commissions 12,514 13,731
Prepaid expenses and other current assets 12,789 18,942
Total current assets 217,876 236,819
Property and equipment, net 23,342 25,249
Goodwill 76,551 76,169
Intangible assets, net 617 732
Other assets 7,756 6,231
Total assets 326,142 345,200
Current Liabilities:    
Accounts payable 614 217
Accrued expenses and other current liabilities 34,300 49,629
Deferred revenue 143,023 145,207
Total current liabilities 177,937 195,053
Non-current liabilities 8,094 8,958
Total liabilities 186,031 204,011
Stockholders' Equity (Note 9):    
Preferred stock, $0.01 par value Authorized - 500 shares; issued and outstanding - none
Common stock, $0.01 par value Authorized - 125,000 shares Issued - 22,564 and 22,432 shares as of June 30, 2018 and December 31, 2017, respectively Outstanding - 17,940 and 18,041 shares as of June 30, 2018 and December 31, 2017, respectively 226 224
Additional paid-in capital 189,554 181,910
Retained earnings 125,698 123,010
Treasury stock - 4,624 and 4,391 shares as of June 30, 2018 and December 31, 2017, respectively, at cost (171,585) (161,943)
Accumulated other comprehensive loss (3,782) (2,012)
Total stockholders’ equity 140,111 141,189
Total liabilities and stockholders’ equity $ 326,142 $ 345,200